血栓通注射液与低分子肝素钙联合治疗不稳定型心绞痛的临床观察

Clinical Observation on Treatment of Unstable Angina by Xueshuantong with Low Molecular Weight Heparin

目的观察血栓通注射液联合低分子肝素钙治疗不稳定型心绞痛的临床疗效。方法将100例病人随机分为两组,对照组在常规治疗的基础上加用低分子肝素钙治疗,治疗组在上述治疗的基础上,加用血栓通治疗。观察治疗前后心绞痛发作次数、心绞痛持续时间、发作间隔时间、24h Holter缺血总时间等变化。结果治疗组总有效率为94%,优于对照组的86%(P<0.05),且治疗组在心绞痛发作次数、持续时间、发作间隔时间及24h Holter缺血总时间改善方面优于对照组(P<0.05)。结论血栓通联合低分子肝素钙治疗不稳定型心绞痛疗效确切。

Objective To study the clinical effects of Xueshuantong with low molecular weight heparin for unstable angina（UA）. Methods One hundred patients （pts） were randomly divided into experiment group and control group. Conventional medical therapy and low molecular heparin were given to both groups. Xueshuantong were used in treatment group. Frequency of ischemia in 24h was examined. Results Total effective rate and improving in experiment group were better than that in control group （P 〈 0. 05）. Conclusion Xeushuantong with low molecular weight heparin was obviously effective for UA.